Recently, CD8+ T cells from a specific cohort of rheumatoid arthritis (RA) patients, unlike naive healthy donors and Systemic Lupus Erythematosus (SLE) patients, have been shown to express elevated surface TLR4 expression and also found to respond upon LPS treatment14. The gene discussed is TLR4; the disease is systemic lupus erythematosus.